Hangzhou Tianmushan Pharmaceutical Enterprise News

ST Eye Medication: Unitai Zhenqing Certified Public Accountants (Special General Partnership) Response to the “Information Disclosure Supervisory Work Letter on ST Eye Medication 2024 Three Quarterly Report”

Dec 4, 2024 00:00

ST Eye Medication: Announcement on Response to the Information Disclosure and Supervision Work Letter of Hangzhou Tianmushan Pharmaceutical Co., Ltd. regarding the report for the third quarter of 2024

Dec 4, 2024 00:00

Announcement on the response letter of Hangzhou Tianmusan Pharmaceutical Co., Ltd. to the information disclosure supervision work letter on the report for the third quarter of 2024

Dec 4, 2024 00:00

Unitai Zhenqing Certified Public Accountants (Special General Partnership) Response to the “Information Disclosure and Supervision Work Letter on ST Eye Drugs 2024 Quarterly Report”

Dec 4, 2024 00:00

Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on receiving the Shanghai Stock Exchange Report for the Third Quarter of 2024 Information Disclosure Supervisory Work Letter

Nov 27, 2024 00:00

ST Eye Medicine: Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the progress of the plan for shareholders holding 5% or more of the shares to increase their holdings and the plan to increase their holdings more than half of the time of the plan

Nov 26, 2024 00:00

Announcement of Resolutions of the 9th Meeting of the 12th Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Nov 14, 2024 00:00

ST Eye Medicine: Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the replacement of the holding subsidiary\'s “Pharmaceutical Business License”

Nov 1, 2024 00:00

ST Eye Medication: Announcement of Resolutions of the 7th Meeting of the 12th Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Oct 11, 2024 00:00

ST Eye Medication: Announcement of Resolutions of the Fourth Meeting of the 12th Supervisory Committee of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Oct 11, 2024 00:00

ST Pharmaceutical: Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the company and indirect controlling shareholders providing guarantees and related transactions for the company\'s wholly-owned subsidiaries to apply for financing from banks

Oct 11, 2024 00:00

Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on renewing the employment of an accounting firm

Oct 11, 2024 00:00

Announcement of Resolutions of the Fourth Meeting of the 12th Board of Supervisors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Oct 11, 2024 00:00

Announcement of Resolutions of the 7th Meeting of the 12th Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Oct 11, 2024 00:00

Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on holding a 2024 semi-annual results briefing

Oct 10, 2024 00:00

ST Eye Medication: Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on receiving a notice of approval for drug re-registration

Sep 13, 2024 00:00

Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the main operating data for the first half year of 2024

Aug 30, 2024 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. Regarding the Guarantee of Comprehensive Credit and Related Party Transactions Provided by the Controlling Shareholder to the Company's Application to Banks.

Aug 24, 2024 00:00

Announcement from Hangzhou Tianmushan Pharmaceutical Co., Ltd. regarding the company and related personnel receiving a warning letter from Zhejiang Securities Regulatory Bureau.

Jul 6, 2024 00:00

Announcement from Hangzhou Tianmushan Pharmaceutical Co., Ltd. regarding pharmaceuticals passing the generic drug consistency evaluation.

Jul 4, 2024 00:00